Skip to main content
    R

    Rockwell Medical Inc (RMTI)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $6.76
    -0.27 (-3.84%)

    Market Cap: $27.92M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Rockwell Medical Inc (RMTI) Financials: Revenue, Profit and Cash Flow

    Updated Nov 12, 2026. Financial statements from company filings, amounts in US dollars.

    Rockwell Medical reported revenue of $69.26M for the fiscal year ended Dec 31, 2025, down 31.8% from the year before. That year, net income was -$5.31M with a net margin of -7.7%, operating cash flow was -$659.00K and free cash flow was -$1.20M. The quarter ended Sep 30, 2026 had revenue of $19.12M and net income of -$2.32M.

    Revenue and Margins

    The operating margin was -6.8% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $53.28M, a compound annual rate of 3.0%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$69.26M-31.8%16.9%-6.8%-7.7%
    Dec 2024$101.49M+21.4%17.2%0.6%-0.5%
    Dec 2023$83.61M+14.8%10.4%-8.0%-10.1%
    Dec 2022$72.81M+17.6%5.6%-23.0%-25.7%
    Dec 2021$61.93M-0.4%-3.9%-49.0%-52.8%
    Dec 2020$62.20M+1.5%4.4%-45.7%-49.7%
    Dec 2019$61.30M-3.3%4.6%-56.3%-55.7%
    Dec 2018$63.39M+10.6%-2.5%-51.2%-50.7%
    Dec 2017$57.30M+7.5%6.5%-45.2%-45.2%
    Dec 2016$53.28MN/A12.7%-37.9%-37.2%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$69.26M$101.49M$83.61M$72.81M$61.93M$62.20M$61.30M$63.39M$57.30M$53.28M
    Cost of revenue$57.56M$84.00M$74.91M$68.73M$64.35M$59.47M$58.46M$64.97M$53.60M$46.53M
    Gross profit$11.70M$17.48M$8.70M$4.08M-$2.42M$2.73M$2.84M-$1.58M$3.70M$6.75M
    Research and development$0$19.00K$1.11M$3.12M$6.83M$7.09M$6.89M$6.74M$6.32M$5.84M
    Operating income-$4.69M$608.00K-$6.67M-$16.78M-$30.34M-$28.42M-$34.52M-$32.44M-$25.92M-$20.21M
    Net income-$5.31M-$480.00K-$8.44M-$18.68M-$32.67M-$30.89M-$34.13M-$32.13M-$25.92M-$19.80M
    EBITDA-$1.88M$3.29M-$3.80M-$13.82M-$27.45M-$26.67M-$31.84M-$32.01MN/A-$19.45M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$19.12M$17.78M$17.34M$18.35M$15.93M$16.07M$18.91M$24.66M$28.32M$25.83M$22.68M$22.09M
    Gross profit$3.11M$3.24M$2.90M$3.88M$2.27M$2.50M$3.04M$3.63M$6.24M$4.55M$3.06M$2.87M
    Operating income-$2.22M-$1.06M-$1.48M-$398.00K-$1.58M-$1.35M-$1.36M-$519.00K$1.94M$515.00K-$1.32M-$547.00K
    Net income-$2.32M-$1.17M-$1.60M-$554.00K-$1.75M-$1.49M-$1.51M-$756.00K$1.66M$343.00K-$1.73M-$1.51M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $10.09M by $621.00K.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$57.15M$59.21M$52.17M$46.63M$48.57M$77.75M$44.32M$52.56M$58.78M$83.15M
    Current assets$38.16M$37.03M$28.77M$35.31M$35.29M$69.47M$36.87M$46.83M$48.83M$78.51M
    Cash and equivalents$10.71M$15.66M$8.98M$10.10M$13.28M$48.68M$11.79M$22.71M$8.41M$17.18M
    Total liabilities$20.16M$26.62M$30.88M$32.53M$46.04M$43.58M$24.00M$25.28M$25.87M$30.20M
    Short-term debt$1.26M$268.00K$2.74M$1.63M$7.38M$0$2.26M$5.55MN/AN/A
    Long-term debt$8.83M$8.47M$8.29M$7.55M$13.19M$20.95M$0N/A$0$0
    Shareholder equity$36.98M$32.59M$21.29M$14.11M$2.54M$34.17M$20.32M$27.28M$32.91M$52.96M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$57.08M$56.53M$57.42M$57.15M$57.49M$52.63M$53.96M$59.21M$57.08M$53.03M$50.72M$52.17M
    Total liabilities$23.95M$21.44M$21.57M$20.16M$20.47M$22.22M$22.44M$26.62M$27.95M$29.53M$30.08M$30.88M
    Cash and equivalents$10.63M$10.52M$9.61M$10.71M$13.61M$12.48M$11.39M$15.66M$12.34M$11.86M$6.64M$8.98M
    Shareholder equity$33.13M$35.09M$35.86M$36.98M$37.02M$30.41M$31.52M$32.59M$29.14M$23.50M$20.64M$21.29M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$659.00K$4.20M-$9.41M-$16.93M-$33.53M-$29.64M-$27.25M-$17.81M-$21.11M-$12.45M
    Capital expenditures$542.00K$1.01M$284.00K$281.00K$522.00K$1.05M$1.34M$994.26K$1.68M$355.26K
    Free cash flow-$1.20M$3.19M-$9.70M-$17.21M-$34.06M-$30.69M-$28.59M-$18.80M-$22.80M-$12.81M
    Dividends paidN/AN/AN/AN/A$6.00K$22.50M$147.90KN/A$0$0
    Share repurchasesN/AN/A$5.00K$106.00K$0$2.53M$2.08MN/AN/AN/A
    Investing cash flow-$8.54M-$4.87M-$3.04M-$2.40M$311.00K$3.21M-$4.75M$32.90M$14.50M-$1.64M
    Financing cash flow$4.25M$7.35M$11.34M$16.15M-$2.18M$63.32M$21.09M$22.00M-$2.16M$80.16K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$1.53M$2.08M-$167.00K$2.29M-$1.31M$1.84M-$3.49M$865.00K$4.28M$1.44M-$2.38M-$43.00K
    Capital expenditures$722.00K$617.00K$425.00K$86.00K$229.00K$164.00K$63.00K$395.00K$191.00K$286.00K$139.00K$43.00K
    Free cash flow-$2.25M$1.46M-$592.00K$2.21M-$1.54M$1.68M-$3.55M$470.00K$4.08M$1.16M-$2.52M-$86.00K
    Last 12 quarters

    Frequently Asked Questions About RMTI

    What is Rockwell Medical's annual revenue?

    Rockwell Medical reported revenue of $69.26M for the fiscal year ended Dec 31, 2025.

    How fast is Rockwell Medical's revenue growing?

    Revenue was down 31.8% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -1.7%.

    Is Rockwell Medical profitable?

    No. Rockwell Medical reported net income of -$5.31M for the fiscal year ended Dec 31, 2025, with a net margin of -7.7%.

    How much free cash flow does RMTI generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$659.00K minus capital expenditures of $542.00K produced free cash flow of -$1.20M.

    How much debt does Rockwell Medical have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $8.83M, short-term debt of $1.26M and cash and equivalents of $10.71M.